CVS Health Raises FY2026 Adj EPS Guidance from $7.00-$7.20 to $7.30-$7.50 vs $7.16 Est; FY2026 Revenue expected to be more than $405.000B vs $404.873B Est

CVS Health Corporation

CVS Health Corporation

CVS

0.00


 

                                   
  Three Months Ended
March 31,		  

Year Ending

December 31,
In billions, except per share amounts 2026   2025   2026 Projected
Total revenues $ 100.4      $ 94.6      At least $405.0
Diluted earnings per share $ 2.30      $ 1.41      $6.24-$6.44
Adjusted EPS (2) $ 2.57      $ 2.25      $7.30-$7.50
Cash flow from operations $ 4.2      $ 4.6      At least $9.5
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.